Amends Medicare to cover Alpha-1 Antitrypsin Deficiency Disorder treatment under Part B.
The John W. Walsh Alpha-1 Home Infusion Act of 2025 amends Medicare to cover Alpha-1 Antitrypsin Deficiency Disorder treatment under Part B. This includes payment for intravenous administration kits and nursing services provided by qualified home infusion therapy suppliers. The treatment must be furnished in the individual's home and under the care of an applicable provider. The amendments apply to items and services furnished on or after January 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.